BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 22, 2021
View Archived Issues
Enrollment begins in phase I/II study of etrumadenant in metastatic colorectal cancer
Read More
Brain-penetrant ALK inhibitor NUV-655 active against treatment-resistant mutations
Read More
Phase I trials planned for new PARP1/2 inhibitor RP-12146
Read More
AP-101 appears to be safe and well tolerated in phase I study in ALS patients
Read More
Aurigene CD73 inhibitor AU-21218 inhibits tumor growth in vivo
Read More
First patients dosed in SAVE 1 phase IIa study ATI-2173
Read More
FDA clears IND application for APB-102 as treatment of SOD1 ALS
Read More
FDA grants IND approval for Zofin in the treatment of osteoarthritis
Read More
Dosing starts in phase I study of AL-102 in combination with WVT-078 in patients with MM
Read More
AUT-00206 improves auditory information processing in patients with schizophrenia
Read More
Novartis and Gilead Sciences patent compounds for herpes virus infections
Read More
Nirogyone Therapeutics discloses MCT inhibitors
Read More
Boragen identifies new JAK inhibitors
Read More
Innovo Therapeutics synthesizes new immunomodulators
Read More
Sangamo Therapeutics presents new compounds for prion diseases
Read More
UCB-0599 shows safety in older individuals with PD with age-related comorbidities
Read More
Targeting the adenosine pathway for cancer immunotherapy
Read More
SAB-185 studied as part of ACTIV-2 trial for treatment of COVID-19
Read More
AN-3025: an anti-TNFR2 antibody for cancer immunotherapy
Read More
Valneva begins pivotal trial of COVID-19 vaccine candidate VLA-2001
Read More
Treatment begins in clinical trial of GNT-0004 gene therapy for Duchenne muscular dystrophy
Read More
Bharat reports second interim analysis of phase III study of Covaxin COVID-19 vaccine candidate
Read More
PCSK9 affects antitumor immunity
Read More